Molecular Neurobiology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of IJMS focuses on publishing high-quality manuscripts that report on a broad range of topics of general interest to those working in the field of molecular neurobiology. Topics include, but are not limited to, the following:
- Neurobiology
- Neurochemistry
- Neurology
- Neuropathology
- Neurophysiology
- Neuropharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology 3.0 (Deadline: 15 October 2023)
- Molecular Mechanism Underlying Memory Modulated by Emotions and Stress (Deadline: 27 October 2023)
- Mitochondrial Dysfunction in Neurodegenerative Diseases (Deadline: 30 October 2023)
- Molecular Mechanisms and Pathophysiology of Anxiety and Depression (Deadline: 31 October 2023)
- Molecular and Cellar Research of Spine and Spinal Cord Injury (Deadline: 31 October 2023)
- Advances in Aging and Alzheimer’s Disease Research: From Molecular Mechanisms to Therapeutics (Deadline: 31 October 2023)
- Recent Molecular Research of Parkinson's Disease (Deadline: 31 October 2023)
- Molecular Mechanisms of Neuropsychiatric Diseases (Deadline: 31 October 2023)
- The Plasticity of the Innervation of the Urogenital System (Deadline: 31 October 2023)
- Research Advances in Neurodegeneration and Neuropathy (Deadline: 31 October 2023)
- Investigating Molecular Footprint in Autism Spectrum Disorders: The Role of Genetics, Epigenetics and Neuroimaging in the Field (Deadline: 31 October 2023)
- Molecular Mechanisms of Neurodegeneration 2023 (Deadline: 31 October 2023)
- Inflammation and Neurological Diseases: Molecular Mechanisms and Therapeutic Implications (Deadline: 31 October 2023)
- Mitochondria as a Cellular Hub in Neurological Disorders 2.0 (Deadline: 31 October 2023)
- Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease (Deadline: 31 October 2023)
- Glycoscience in Neurodegenerative Disorders (Deadline: 31 October 2023)
- Molecular Advances in Pathogenesis and Treatment of Diabetic Retinopathy (Deadline: 31 October 2023)
- Breakthroughs in Diagnostic Prediction and Fundamental Therapeutics of Dementia and Movement Disorders (Deadline: 31 October 2023)
- Recent Advances in the Research of Mental Disorders (Deadline: 31 October 2023)
- Molecular Mechanisms of Neuromuscular Transmission in Health and Disease (Deadline: 31 October 2023)
- Current Insights on Neuroprotection (Deadline: 31 October 2023)
- Activation of the Blood–Brain Barrier and Neurological Dysfunction (Deadline: 31 October 2023)
- Molecular Insight into Epilepsy (Deadline: 31 October 2023)
- The Link between Stem Cells and Nervous System (Deadline: 31 October 2023)
- Trends in Neuroscience: From Molecular Mechanisms to Innovative Therapeutics (Deadline: 31 October 2023)
- Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies 2.0 (Deadline: 31 October 2023)
- Neuropharmacology and Neurodegenerative Diseases 2.0 (Deadline: 31 October 2023)
- RNA Biomarkers in Neuropsychiatric Disorders (Deadline: 31 October 2023)
- Blast-Induced Neurotrauma: Molecular Mechanisms Supported by Comparative Experimental and Clinical Findings (Deadline: 31 October 2023)
- Molecular Mechanism of Oxidative Stress in Neurodegeneration (Deadline: 31 October 2023)
- Physiology and Pathology of Neurons 2.0 (Deadline: 31 October 2023)
- The Multiple Mechanisms Underlying Neuropathic Pain (III) (Deadline: 31 October 2023)
- Molecular Advances in Drug Discovery and Development for Neurodegenerative and Neuropsychiatric Disorders (Deadline: 31 October 2023)
- Genetics and Molecular Mechanisms in Psychological and Neuropsychiatric Disorders (Deadline: 31 October 2023)
- New Trends in Molecular Research of Aneurysm and Brain Injury (Deadline: 31 October 2023)
- Recent Research of Gut Microbiota-Brain Axis and Neurons in Psychiatric Disorders (Deadline: 31 October 2023)
- Neural Crest Development in Health and Disease (Volume 2) (Deadline: 31 October 2023)
- TDP-43 Biology and Pathology (Deadline: 31 October 2023)
- Blood-Based Biomarkers for Alzheimer’s Disease (Deadline: 31 October 2023)
- Study on Brain Plasticity from Neonatal to the Old Age (Deadline: 10 November 2023)
- Molecular and Metabolic Insights into Neuroinflammation and Neurodegeneration (Deadline: 15 November 2023)
- Neuroprotective Effect of Glutathione 2.0 (Deadline: 15 November 2023)
- Molecular and Cellular Mechanisms on Autism Spectrum Disorder (Deadline: 15 November 2023)
- Biological Biomarkers of Mild Traumatic Brain Injury (Deadline: 15 November 2023)
- Genetic Heterogeneity and Molecular Mechanism of Neurodevelopmental Disorders (Deadline: 15 November 2023)
- Molecular Mechanisms Subserving Taste and Olfaction Systems (Deadline: 20 November 2023)
- Molecular and Genetic Studies in Neurocutaneous Syndromes (Deadline: 24 November 2023)
- Molecular Signaling Pathways in Brain Pathology 2.0 (Deadline: 25 November 2023)
- Neurobiology of Protein Synuclein 2.0 (Deadline: 29 November 2023)
- Molecular Mechanisms of Dementia 2.0 (Deadline: 29 November 2023)
- Focus on Hippocampus Biology: From Neurophysiology to Dysfunctions (Deadline: 30 November 2023)
- Recent Advances in Alzheimer’s Disease (Deadline: 30 November 2023)
- Alzheimer's Disease: From Pathogenic Mechanisms to Therapy (Deadline: 30 November 2023)
- Stem Cell Therapy for Neurological Diseases (Deadline: 30 November 2023)
- Neurometabolic Disorders in the Adults (Deadline: 30 November 2023)
- Molecular and Cellular Neurobiology of Migraine 2.0 (Deadline: 30 November 2023)
- Molecular Mechanisms and Pathophysiology of Acute Stroke 2.0 (Deadline: 30 November 2023)
- Mitochondria as Potential Targets in Alzheimer’s Disease Therapy (Deadline: 30 November 2023)
- Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders 3.0 (Deadline: 30 November 2023)
- Steroids and Neuropsychiatric Disorders (Deadline: 30 November 2023)
- New Advances in Glioma Knowledge: From Genome to Signal Pathways Alterations (Deadline: 30 November 2023)
- Molecular Research in Psychiatric Disorders (Deadline: 30 November 2023)
- Molecular Signals and Genetic Regulations of Neurological Disorders 2.0 (Deadline: 30 November 2023)
- New Targets and Approaches for the Treatment of Alzheimer's Disease and Related Disorders (Deadline: 30 November 2023)
- Ion Channels in the Nervous System (Deadline: 30 November 2023)
- Neurotrophins: Roles and Function in Human Diseases 2.0 (Deadline: 30 November 2023)
- Molecular and Electrophysiological Properties of Motoneurons in the Mammalian Brain and Spinal Cord (Deadline: 30 November 2023)
- Role of Glutamate Receptors in CNS Diseases (Deadline: 30 November 2023)
- New Trends in Alzheimer's Disease Research: From Molecular Mechanisms to Therapeutics (Deadline: 30 November 2023)
- Brain Structural Plasticity: Theme and Variations (Deadline: 30 November 2023)
- Mechanisms and Interventions for Neurological and Psychological Disorders 2.0 (Deadline: 30 November 2023)
- Immunity in Neurodegenerative Diseases: Systemic Immune Imbalance, Neuroinflammation, and Beyond (Deadline: 30 November 2023)
- New Advances in Drug-Induced Neurogenesis (Deadline: 30 November 2023)
- SARS-CoV-2 Infection and Neuroinflammation (Deadline: 30 November 2023)
- Molecular Research on Depression (Deadline: 30 November 2023)
- Molecular Brain Pathology: From Stress to Neurodegeneration (Deadline: 30 November 2023)
- Pathogenesis of Diseases of the Central Nervous System 2.0 (Deadline: 30 November 2023)
- Progress in Analytical Techniques and Chemical Analysis in Molecular and Cellular Neuroscience (Deadline: 30 November 2023)
- Molecular Research on Neuronal Cell Death and Neurogenesis (Deadline: 30 November 2023)
- Alzheimer’s Disease: From Molecular Basis to Therapy 2.0 (Deadline: 15 December 2023)
- Metabolic and Neurodegenerative Disorders: The Molecular and Cellular Mechanisms (Deadline: 15 December 2023)
- Molecular Mechanisms of Schizophrenia and Novel Targets 2.0 (Deadline: 20 December 2023)
- Disorders in Brain Development and Nervous System: Key Molecules and Pathology (Deadline: 20 December 2023)
- The Latest Research for Neuropharmacology and Neurotransmission (Deadline: 20 December 2023)
- Amyotrophic Lateral Sclerosis as a Systemic Disease 2.0 (Deadline: 20 December 2023)
- Molecular Advances in Neuroradiology (Deadline: 20 December 2023)
- Molecular and Physiological Mechanisms of Traumatic Brain Injury (Deadline: 25 December 2023)
- Retinal Diseases and Cell Signaling (Deadline: 30 December 2023)
- Translational and Molecular Research of Neurological Disorders (Deadline: 30 December 2023)
- Neurotransmitters and Hormones in Neurological Disorders (Deadline: 30 December 2023)
- Current Insights into the Neuronal Calcium Sensor DREAM and Related KChIP Proteins (Deadline: 30 December 2023)
- Tau Pathobiology in Neurodegenerative Diseases: From Molecular Mechanisms to Therapeutic Advances (Deadline: 30 December 2023)
- Neuroinflammation: From Molecular Basis to Therapy (Deadline: 30 December 2023)
- Multiple Sclerosis and Demyelinating Pathologies: Mechanisms and Cutting-Edge Therapies 2.0 (Deadline: 30 December 2023)
- Synaptic Plasticity and Signaling Pathways in Neurodevelopmental Disorders (NDDs) (Deadline: 30 December 2023)
- Cognitive Dysfunction: Molecular Research and Novel Therapy (Deadline: 30 December 2023)
- Neurospecific Substances as Biomarkers of Central Nervous System in Periphery (Deadline: 31 December 2023)
- Molecular Logics in Human Neuroscience (Deadline: 31 December 2023)
- Novel Hypotheses for Alzheimer's Disease (Deadline: 31 December 2023)
- Ribbon Synapses: Molecular Mechanisms of Synaptic Signaling and Involvement in Diseases 2.0 (Deadline: 31 December 2023)
- Ischemic Genetic Pathology in Neurodegenerative Diseases (Deadline: 31 December 2023)
- The Cellular, Synaptic and Molecular Mechanisms of Action of Central Nervous System Drugs 2.0 (Deadline: 31 December 2023)
- Neurodevelopmental Disorders: From Molecular and Cellular Mechanism to Therapeutic Perspective (Deadline: 31 December 2023)
- CNS Drug Action in Neurodegenerative Diseases 3.0 (Deadline: 31 December 2023)
- Molecular Research of Amyotrophic Lateral Sclerosis (Deadline: 31 December 2023)
- Molecular and Cellular Mechanism in Alzheimer's Disease (Deadline: 31 December 2023)
- Molecular Researches on Ischemic Stroke 2.0 (Deadline: 31 December 2023)
- Dopamine, Histamine, Serotonin—Receptors, Ligands and Their Biological Role in Central Nervous System Diseases (Deadline: 31 December 2023)
- Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases 3.0 (Deadline: 31 December 2023)
- ER Stress, Mitochondrial Dysfunction, and Neuroinflammation in Neurodegenerative Diseases (Deadline: 31 December 2023)
- Molecular Advances in Nervous System Disorders (Deadline: 31 December 2023)
- Synucleins in Neurodegeneration (Deadline: 31 December 2023)
- Nutrients and Gut Microbiota-Derived Nutrients in Brain Homeostasis: From Basic Mechanisms to Diseases and Identification of Possible Therapeutic Targets (Deadline: 31 December 2023)
- Roles of Glia in CNS: Toward the Development of New Antidepressant Strategies? (Deadline: 31 December 2023)
- Molecular Advances in Rare Inherited Neuromuscular Diseases: Therapeutic and Diagnostic (Deadline: 31 December 2023)
- Microanatomical and Molecular Updates on Brain Aging (Deadline: 31 December 2023)
- Advances in Stress and Depression Research: Neurobiology, Models, Biomarkers and Therapies 2.0 (Deadline: 31 December 2023)
- New Molecular Progression of Stem Cell Therapy for Neurological Disorders (Deadline: 31 December 2023)
- The Function of Glial Cells in the Nervous System (Deadline: 31 December 2023)
- Proposal of a Special Issue On: Basic, Translational and Clinical Research on Dementia (Deadline: 31 December 2023)
- Molecular Mechanism of Alzheimer's Disease IV (Deadline: 31 December 2023)
- Molecular Advances in Epilepsy and Seizures (Deadline: 31 December 2023)
- Genetic Research and Omics in Neuroinflammatory Diseases (Deadline: 31 December 2023)
- Peripheral Neuropathies: Molecular Research and Novel Therapy (Deadline: 31 December 2023)
- Regulation and Function of Adult Neurogenesis (Deadline: 31 December 2023)
- Neurodegeneration and Countermeasures to Slow Down Its Onset (Deadline: 31 December 2023)
- Neuroprotective Strategies 2023 (Deadline: 31 December 2023)
- Neurobiological Mechanisms of Addictive Disorders (Deadline: 31 December 2023)
- Latest Research on Brain Science: Based on Neurogenomics (Deadline: 31 December 2023)
- Vascular, Oxidative and Inflammatory Dysregulation in Neurodegenerative Diseases: Current Status and Future Therapeutic Perspectives (Deadline: 31 December 2023)
- Translational Advances in Alzheimer's, Parkinson's, and Other Dementia: Molecular Mechanisms, Biomarkers, Diagnosis, and Therapies (Deadline: 31 December 2023)
- Animal Research Model for Neurological Diseases (Deadline: 31 December 2023)
- Structural Biology of Peptides and Proteins in Alzheimer's Disease and Related Disorders (Deadline: 31 December 2023)
- New Insights of Biomarkers in Neurodegenerative Diseases (Deadline: 1 January 2024)
- The Role of Dopamine Neurotransmitters in Neurological Diseases: New Sight (Deadline: 15 January 2024)
- Neuromodulatory Effects of Serotonin (Deadline: 15 January 2024)
- Novel Concepts, New Perspectives, and Current Therapies for Parkinson's Disease (Deadline: 15 January 2024)
- Brain-Body Bidirectional Communication and Its Relevance for Cerebrovascular Diseases (Deadline: 15 January 2024)
- Neurodegenerative Diseases: Molecular Mechanisms and Therapies, 2nd Edition (Deadline: 15 January 2024)
- Natural History in Neurogenetic Disorders: Molecular Characterization in the NGS Era (Deadline: 20 January 2024)
- Neurotransmitters in Neurodegenerative Diseases (Deadline: 30 January 2024)
- Dementia: From Molecular Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 January 2024)
- Bioactive Lipids and Cannabinoids: Key Players in Neuropsychiatric Disorders and Beyond (Deadline: 31 January 2024)
- Peripheral Biomarkers in Neurodegenerative Diseases 4.0 (Deadline: 31 January 2024)
- Advances in the Search for Protective Agents against Amyloid β-Induced Brain Degeneration (Deadline: 31 January 2024)
- Mechanisms of Antipsychotic Action: From the Researcher Bench to the Patient Bedside 2.0 (Deadline: 31 January 2024)
- Inflammaging and Brain Aging (Deadline: 31 January 2024)
- Epilepsy: From Molecular Basis to Therapy (Deadline: 31 January 2024)
- Neuropathological Features of Aging and Neurodegenerative Diseases (Deadline: 31 January 2024)
- Molecular Advances in Alzheimer's Disease 2.0 (Deadline: 31 January 2024)
- New Insights in Prion Diseases (Deadline: 31 January 2024)
- New Mechanisms and Therapeutics in Neurological Diseases 3.0 (Deadline: 31 January 2024)
- Emerging Neuroprotective and Regenerative Strategies for the Treatment of Demyelinating Disorders of the Central Nervous (Deadline: 31 January 2024)
- Advances in Neurodegenerative Diseases Research and Therapy 2.0 (Deadline: 15 February 2024)
- Biostatistics in Brain Diseases - Future Approaches (Deadline: 15 February 2024)
- Prodromal Biomarkers for Neurodegenerative Diseases (Deadline: 15 February 2024)
- Molecular Advances in Psychiatric Therapies (Deadline: 15 February 2024)
- Challenges and Innovation in Neurodegenerative Diseases (Deadline: 23 February 2024)
- Recent Progress in Neuro-Oncology and Neuro-Inflammation: Novel Diagnostic and Therapeutic Tools (Deadline: 27 February 2024)
- Molecular Pathogenesis of Ischemic and Hemorrhagic Strokes (Deadline: 28 February 2024)
- Molecular Study and Treatment of Motor Neuron Diseases (Deadline: 28 February 2024)
- Neuroinflammation and Neurodegeneration: Molecular Mechanism and Novel Therapy (Deadline: 28 February 2024)
- Molecular Research on the Effects of Mimicking Exercise on Brain Health (Deadline: 28 February 2024)
- The Role of Stem Cell in Neurodegenerative Diseases (Deadline: 29 February 2024)
- Neurodegenerative Disease: From Molecular Basis to Therapy, 2nd Edition (Deadline: 29 February 2024)
- Enhancing Neurological Recovery after Stroke: Potential Therapies and Mechanisms (Deadline: 29 February 2024)
- Recent Molecular Research of Neuroscience: Application of Animal Models (Deadline: 29 February 2024)
- Anesthetic and Sedative Actions on Nervous System Development (Deadline: 29 February 2024)
- Mechanisms of Neurotoxicity (Deadline: 29 February 2024)
- The Roles of Histamine and Its Receptor Ligands in Central Nervous System Disorders (Deadline: 29 February 2024)
- New Trends in Research on Cerebral Ischemia (Deadline: 29 February 2024)
- Role of Dopamine in Health and Disease: Biological Aspect 2.0 (Deadline: 29 February 2024)
- Neuroinflammation: Advancements in Pathophysiology and Therapies (Deadline: 29 February 2024)
- Diagnostic Tools for Neuropsychological Disorders (Deadline: 29 February 2024)
- Molecular Research in Epilepsy and Epileptogenesis (Deadline: 29 February 2024)
- Interactions between the Nervous System and Gastrointestinal Motility (Deadline: 29 February 2024)
- Alzheimer’s Disease and Other Dementias—Molecular Therapeutic Approaches (Deadline: 29 February 2024)
- Advances in Peripheral Nerve Regeneration (Deadline: 29 February 2024)
- Neuroinflammatory Mediator in Neurodegenerative Disease (Deadline: 29 February 2024)
- Molecular Mechanisms of Neurological and Psychiatric Disease: A Decade of Progress (Deadline: 29 February 2024)
- Advances in Research on Neurogenesis 3.0 (Deadline: 29 February 2024)
- Biomarkers in Neoplastic and Degenerative CNS Diseases: Defining New Frontiers in Clinical Usefulness and Therapeutic Molecular Target (Deadline: 29 February 2024)
- Recent Advances in Microglia Research (Deadline: 29 February 2024)
- Circulating Biomarkers for the Diagnosis of Neurobiological Diseases (Deadline: 29 February 2024)
- New Insights into Synapse Structure and Function (Deadline: 10 March 2024)
- Molecular Research on Neurodegenerative Diseases 4.0 (Deadline: 10 March 2024)
- Modeling Neurological Disorders in Experimental Animals: New Insights and Emerging Roles 3.0 (Deadline: 20 March 2024)
- From Molecular Insights to Novel Therapies: Neurological Diseases (Deadline: 25 March 2024)
- Dysfunctional Neural Circuits and Impairments in Brain Function (Deadline: 25 March 2024)
- New Advances of Proteins in Neuroinflammation (Deadline: 25 March 2024)
- Molecular Mechanisms of Genetic Variants of Parkinson's Disease (Deadline: 31 March 2024)
- Molecular Research on Mental Disorders 2.0 (Deadline: 31 March 2024)
- Blood-Brain Barrier in Neuroinflammation and Neurological Diseases (Deadline: 31 March 2024)
- Traumatic Brain Injury/Chronic Traumatic Encephalopathy as Cause of Alzheimer’s Disease: Physics and Molecular Biology in the Genesis of Neurodegeneration? (Deadline: 31 March 2024)
- Novel Therapeutic Strategies for Neurodegenerative Disease (Deadline: 31 March 2024)
- Molecular Research of Alzheimer’s Disease and Neurodegeneration: The SHIELD Approach (Deadline: 31 March 2024)
- The Role of Microglia in Neurological Disorders (Deadline: 31 March 2024)
- Genomic Research in Neurobiology (Deadline: 31 March 2024)
- Emerging Strategies for Regulating the Axonal Growth, Guidance and Neural Tissue Regeneration (Deadline: 31 March 2024)
- Novel Extracellular Vesicle-Based Therapy for Central Nervous System Diseases (Deadline: 31 March 2024)
- Neural Stem Cells: Focusing on Disease Modeling and Translational Application 2.0 (Deadline: 31 March 2024)
- Molecular Advances in Neuromuscular Disorder: Spinal Muscular Atrophy and More (Deadline: 31 March 2024)
- Mechanisms of the Endocannabinoid System and Their Role in Neurophysiology and Psychopathology (Deadline: 31 March 2024)
- Novel Hypotheses for Dementia and Neurodegenerative Diseases: From Molecular Mechanisms to Therapies (Deadline: 30 April 2024)
- Multiplicity of Cerebrospinal Fluid Functions in Health and Disease (Deadline: 20 May 2024)
- Genotoxicity in Neurodegenerative Disease and Neuropsychiatric Disorders (Deadline: 31 May 2024)
- Molecular Mechanisms and Pathophysiology of Cerebral Gliomas: Towards Development of New Treatments (Deadline: 15 June 2024)
- Molecular, Cellular, and Blood Biomarkers in Acute Ischemic Stroke (Deadline: 30 June 2024)
- Advances in Research on Neurotransmitters (Deadline: 15 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
